PharmacyChecker Blog

Helping Americans Get The Truth About Prescription Drug Savings
Published by:

American Made, Cheaper Abroad: Cardura XL

Cardura XL packaging

Cardura XL packaging

A weekly series identifying prescription drugs manufactured in America and their prices.

Cardura XL (doxazosin mesylate extended release tablets), a product marketed by drug giant Pfizer, is used to treat signs and symptoms of benign prostatic hyperplasia, or an increase in prostate size. Cardura XL is manufactured in the U.S., but available at a much lower price in foreign pharmacies. At a Rite-Aid in New York City, 30 pills (4 mg) costs $94. The lowest price from a PharmacyChecker.com approved pharmacy is $26. That’s a 72% savings or $816 over one year.

Share
Tagged with: , ,

American Made, Cheaper Abroad: Lumigan Eyedrops

Lumigan 3 ml packaging

A weekly series identifying prescription drugs manufactured in America and their prices.

Lumigan (bimatoprost) ophthalmic solution is used for the treatment symptoms from glaucoma or ocular hypertension. Lumigan, a product of the drug company Allergan, is manufactured in the U.S., but the price at U.S. pharmacies is about six times higher than in other countries. You can save around 80% by ordering it from a verified international online pharmacy: one 2.5 ml vial of Lumigan costs $114 at a Rite-Aid in New York City, but a 3 ml vial is only $22 from a PharmacyChecker.com-approved pharmacy.

Share
Tagged with: , ,

PharmacyChecker.com Vice President Decries Lack of Government Action To Help Americans With High Drug Prices

A popular industry/government blog called Pharmalot, now Pharmalive.com/pharmalot published an op-ed written by our vice president, Gabriel Levitt, explaining why high drug prices are literally making Americans sick, costing taxpayers hundreds of billions of dollars, and how so little is being done by the government. The fact is that American consumers and taxpayers are getting pilloried under the weight of high drug prices. Personal drug importation through safe international online pharmacies is a life saver – sometimes literally because those who go without medication due to cost sometimes die. This won’t change until drug prices come down in America.

Share
Tagged with: ,

American Made, Cheaper Abroad: Invega

A weekly series identifying prescription drugs manufactured in America and their prices.

French Invega Packaging

Invega (paliperidone) tablets, a product of Jansen Pharmaceuticals, are used to treat schizophrenia and schizoaffective disorder in adults and adolescents. Invega is manufactured in the U.S., but is cheaper when ordered in other countries, even for Americans. The price at a New York City CVS for a 90-day supply of Invega 6 mg is $1,932, and that’s even taking into account the savings from a coupon. By ordering from a safe international online pharmacy, the price is only $580. Over one year a consumer could save $5,408 or 70%!

Share
Tagged with: , , ,

American Made, Cheaper Abroad: Pataday

Pataday in its American packaging

A weekly series identifying prescription drugs manufactured in America and their prices.

Pataday (olopatadine hydrochloride ophthalmic solution) is a solution used for the treatment of itchy or watering eyes caused by allergies. Pataday is manufactured in the U.S., but that doesn’t mean that’s where it’s cheapest for Americans. In fact, you can save 79% by ordering it from a verified foreign online pharmacy: one 2.5 ml vial of Pataday costs $161 at a Walgreens in New York City, but only $34 from a PharmacyChecker.com-approved pharmacy.

Share
Tagged with: , ,

Obamacare Out-of-Pocket Cost Delays A Bad Prescription for Consumers

Americans with high out-of-pocket healthcare costs will be disappointed with a new Affordable Care Act (Obamacare) delay announced by the Obama administration. The delay allows insurers and employers using more than one benefits administrator to wait one extra year – until 2015 – before being required to limit out-of-pocket costs to a maximum of $6,350 for an individual or $12,700 for a family, as mandated by the law. Instead, they will be permitted to maintain separate out-of-pocket limits for various benefits. For example, a patient may have a $6,350 cap for doctor visits and another $6,350 cap for prescription drugs.

Except that there may actually be no cap at all for prescription drug plans. Plans currently without out-of-pocket caps will not be subject to mandatory ones in 2014.

The only reason for the delay mentioned in a recent New York Times article is a technological problem. Many companies use different administrators for different benefits, and their computer systems are currently unable to combine all costs from different programs for a given patient. As the New York Times says, “In many cases, the companies have separate computer systems that cannot communicate with one another.” Companies need more time to upgrade their software to accommodate this.

Obamacare was passed in 2010, and the mandatory out-of-pocket limits were slated to go into effect in 2014, giving companies four years to figure out how to get their computers to talk to each other.

This does not seem like a legitimate reason to delay prescription drug spending caps. Fifty million adults did not fill a prescription last year due to cost; access to affordable medicine is a big problem in the United States, and failure to implement out-of-pocket spending limits will likely keep prescriptions unfilled.

Fortunately, safe international pharmacies offer low prices to Americans. As of last November, prices for brand name medication were 85% less expensive from them when compared to U.S. pharmacies. If you choose to order medication from abroad, make sure the pharmacy is a PharmacyChecker.com verified online pharmacy.

Share